Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.
Giovanni CaocciOlga MulasIsabella CapodannoElisabetta AbruzzeseAlessandra IurloLuigiana LucianoFrancesco AlbanoMario AnnunziataMario TiribelliMassimiliano BonifacioSara GalimbertiFausto CastagnettiNicola SgherzaFabio StagnoAntonella GozziniEster Maria OrlandiDebora LuziGianni BinottoPatrizia PregnoClaudio FozzaFabio EfficaceMaria Pina SimulaMalgorzata Monika TrawinskaDaniele CattaneoFiorenza De GregorioImmacolata AttolicoRossella StellaLuigi ScaffidiClaudia BaratèGabriele GugliottaEmilia ScalzulliChiara ElenaFrancesca PirilloRobin FoàMassimo BrecciaGiorgio La NasaPublished in: Blood cancer journal (2020)